BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2013
View Archived Issues
New milestone under Ono Pharmaceutical and Receptos' GPCR collaboration
Read More
Novel nanoparticles shown to suppress choroidal neovascularization
Read More
Sirolimus demonstrates safety in patients with uveitis
Read More
ADMA Biologics begins pivotal phase III study of RI-002 in PIDD
Read More
Hangzhou Bensheng Pharmaceutical divulges novel agents for cancer
Read More
GlaxoSmithKline synthesizes bromodomain-containing protein inhibitor
Read More
reMYND patents new agents for tauopathies
Read More
Janssen and Bayer launch global cardiovascular research program for Xarelto
Read More
Incyte Corp. prepares new series of JAK1 inhibitors
Read More
Vitamin D deficiency associated with psoriasis severity
Read More
New mutations identified in Gorlin-Goltz syndrome
Read More
Norendoxifen as a new lead compound for aromatase inhibitor development
Read More
Researchers at Piramal Imaging design new diagnostics for thrombosis
Read More
Cellceutix plans future Kevetrin trials
Read More
Merck & Co. submits BLA for ragweed AIT
Read More
Non-inferiority reported in phase III trial of the seasonal flu vaccine ASP-7374
Read More
Theravance grants Clinigen exclusive commercialization rights to Vibativ in the E.U.
Read More
Retrophin reports data from preclinical studies of RE-024
Read More
Amgen synthesizes novel sodium channel blockers
Read More
Aeterna Zentaris to stop phase III trial of combination regimen using perifosine
Read More
Sosei initiates phase III study of mucoadhesive buccal tablet for oropharyngeal candidiasis
Read More
ZIOPHARM Oncology begins phase II study of Ad-RTS IL-12 combined with palifosfamide
Read More
Autologous CDC therapy proves to be safe and effective in patients post-MI
Read More
TONIX Pharmaceuticals and the FDA discuss NDA plan for TNX-102
Read More
NeuroVive acquires novel cyclophilin inhibitors from Biotica
Read More
Astellas and Ambit terminate collaboration for FLT3 kinase inhibitors
Read More
Telormedix commences enrollment in phase II trial in bladder cancer
Read More